Literature DB >> 21301788

A novel missense mutation in the FGB g. 3354 T>A (p. Y41N), fibrinogen Caracas VIII.

Rita Marchi1, Héctor Rojas, Michael Meyer, Oscar Castillo, Arlette De Sáez Ruiz, John W Weisel.   

Abstract

A novel dysfibrinogenaemia with a replacement of Tyr by Asn at Bβ41 has been discovered (fibrinogen Caracas VIII). An asymptomatic 39-year-old male was diagnosed as having dysfibrinogenaemia due to a mildly prolonged thrombin time (+ 5.8 seconds); his fibrinogen concentration was in the low normal range, both by Clauss and gravimetric determination, 1.9 g/l and 2.1 g/l, respectively. The plasma polymerization process was slightly impaired, characterised by a mildly prolonged lag time and a slightly increased final turbidity. Permeation through the patients' clots was dramatically increased, with the Darcy constant around four times greater than that of the control (22 ± 2 x 10(-9) cm² compared to 6 ± 0.5 x 10(-9) cm² in controls). The plasma fibrin structure of the patient, by scanning electron microscopy, featured a mesh composed of thick fibres (148 ± 50 nm vs. 120 ± 31 nm in controls, p<0.05) and larger pores than those of the control fibrin clot. The viscoelastic properties of the clot from the patient were also altered, as the storage modulus (G', 310 ± 30) was much lower than in the control (831 ± 111) (p ≤0.005). The interaction of the fibrin clot with a monolayer of human microvascular endothelial cells, by confocal laser microscopy, revealed that the patients' fibrin network had less interaction with the cells. These results demonstrate the significance of the amino terminal end of the β chain of fibrin in the polymerisation process and its consequences on the clot organisation on the surface of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301788      PMCID: PMC3337776          DOI: 10.1160/TH10-03-0179

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  35 in total

1.  Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled.

Authors:  J W Weisel; C Nagaswami
Journal:  Biophys J       Date:  1992-07       Impact factor: 4.033

2.  [STUDY OF THE PHENOMENA OF COAGULATION AND FIBRINOLYSIS BY A SIMPLE METHOD OF CONTINUOUS OPTICAL REGISTRATION].

Authors:  C A BOUVIER; J GRUENDLINGER
Journal:  Schweiz Med Wochenschr       Date:  1963-10-12

3.  The determination of plasma fibrinogen by the clot-weight method.

Authors:  I C INGRAM
Journal:  Biochem J       Date:  1952-08       Impact factor: 3.857

4.  Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.

Authors:  L A Bunce; L A Sporn; C W Francis
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 5.  Fibrinogen and fibrin.

Authors:  John W Weisel
Journal:  Adv Protein Chem       Date:  2005

6.  Three-dimensional reconstruction of fibrin clot networks from stereoscopic intermediate voltage electron microscope images and analysis of branching.

Authors:  T C Baradet; J C Haselgrove; J W Weisel
Journal:  Biophys J       Date:  1995-04       Impact factor: 4.033

7.  Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains.

Authors:  K Yokoyama; X P Zhang; L Medved; Y Takada
Journal:  Biochemistry       Date:  1999-05-04       Impact factor: 3.162

Review 8.  Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.

Authors:  V W van Hinsbergh; P Koolwijk; R Hanemaaijer
Journal:  EXS       Date:  1997

9.  Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin.

Authors:  T L Bach; C Barsigian; C H Yaen; J Martinez
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

10.  Evidence of intramolecular cross-linked A alpha.gamma chain heterodimers in plasma fibrinogen.

Authors:  K R Siebenlist; M W Mosesson
Journal:  Biochemistry       Date:  1996-05-07       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.